Risk of second bone sarcoma following childhood cancer: Role of radiation therapy treatment

Radiation and Environmental Biophysics

Volumn 53, Issue 2, 2014, Pages 381-390

  Schwartz, Boris ^a,b   Benadjaoud, Mohamed Amine ^a,b   Cléro, Enora ^a,b   Haddy, Nadia ^a,b   El Fayech, Chiraz ^a,b   Guibout, Catherine ^a,b   Teinturier, Cécile ^a,b   Oberlin, Odile ^a,b   Veres, Cristina ^a,b   Pacquement, Hélène ^c   Munzer, Martine ^d   Nguyen, Tan Dat ^d   Bondiau, Pierre Yves ^e   Berchery, Delphine ^f   Laprie, Anne ^f   Hawkins, Mike ^g   Winter, David ^g   Lefkopoulos, Dimitri ^a   Chavaudra, Jean ^a   Rubino, Carole ^a,b   Diallo, Ibrahima ^a,b   Bénichou, Jacques ^h,i,j   De Vathaire, Florent ^a,b   more..

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT CURIE   (France)

^d INSTITUT JEAN GODINOT   (France)

^e CENTRE ANTOINE LACASSAGNE   (France)

^f INSTITUT CLAUDIUS REGAUD   (France)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h INSERM   (France)

ⁱ ROUEN UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ DE ROUEN   (France)

more..

Author keywords

Bone sarcoma; Childhood cancer; Iatrogenous effects; Radiation therapy; Secondary tumor

Indexed keywords

BONE; DISEASES; DOSIMETRY; RISK ASSESSMENT; TUMORS;

CHILDHOOD CANCERS; CONFIDENCE INTERVAL; DOSE RESPONSE RELATIONSHIPS; EXCESS RELATIVE RISKS; IATROGENOUS EFFECTS; INNOVATIVE METHODOLOGIES; RADIATION THERAPY TREATMENT; THERAPEUTIC SOLUTIONS;

RADIOTHERAPY;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHEMICALLY INDUCED; CHILD; COHORT ANALYSIS; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NEWBORN; PRESCHOOL CHILD; RADIATION DOSE; RADIATION RESPONSE; RADIOTHERAPY; RISK; SARCOMA; STATISTICAL MODEL; SURVIVOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK; SARCOMA; SURVIVORS; YOUNG ADULT;

EID: 84902533450     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-013-0510-9     Document Type: Conference Paper

References (36)

1. Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM, Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS (2006) Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24(3):476-483
2. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, Binder-Foucard F, Colonna M, Daubisse L, Hédelin G, Launoy G, Le Stang N, Maynadié M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Chérié-Challine L, Estève J, Remontet L, Velten M (2008) Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56(3):159-175
3. Berrington de Gonzalez A, Kutsenko A, Rajaraman P (2012) Sarcoma risk after radiation exposure. Clin Sarcoma Res 2(1):18
4. BreslowNE,DayNE (1987) Statisticalmethods in cancer research. IARC workshop 25-27May 1983. IARC Science Publication 82:1-406
5. Cardous-Ubbink MC, Heinen RC, Bakker PJ, Bakker PJ, van den Berg H, Oldenburger F, Caron HN, Voûte PA, van Leeuwen FE (2007) Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 43(2):351-362
6. Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J (1996) Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 38(3):269-271
7. Fine PF, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. JASA 94:496-509
8. Francois P, Beurtheret C, Dutreix A (1988a) Calculation of the dose delivered to organs outside the radiation beams. Med Phys 15(6):879-883
9. Francois P, Beurtheret C, Dutreix A, De Vathaire F (1988b) A mathematical child phantom for the calculation of dose to the organs at risk. Med Phys 15(3):328-333
10. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102(14):1083-1095
11. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323(6089):643-646
12. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695-706
13. Hawkins MM, Lancashire ER, Winter DL, Frobisher C, Reulen RC, Taylor AJ, Stevens MC, Jenney M (2008) The British Childhood Cancer Survivor Study: objectives, methods, population structure, response rates and initial descriptive information. Pediatr Blood Cancer 50(5):1018-1025
14. Hawkins MM, Swerdlow AJ (1992) Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. Br J Cancer 66(2):408-413
15. Hawkins MM, Wilson LM, Burton HS, Potok MH, Winter DL, Marsden HB, Stovall MA (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88(5):270-278
16. Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, Mertens A, Meadows A, Neglia JP, Hammond S, Whitton J, Inskip PD, Robison LL, Diller L (2012) Risks factors associated with secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Int J Radiat Oncol Biol Phys 84:224-230
17. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr (2005) Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 23(10):2272-2279
18. Le Vu B, de Vathaire F, Shamsaldin A, Hawkins MM, Grimaud E, Hardiman C, Diallo I, Vassal G, Bessa E, Campbell S, Panis X, Daly-Schveitzer N, Lagrange JL, Zucker JM, Eschwège F, Chavaudra J, Lemerle J (1998) Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer 77(3):370-377
19. Marubini E, Valsecchi MG (1995) Analysing survival data from clinical trials and observational studies. Wiley, Hoboken, NJ
20. Moolgavkar SH, Venzon DJ (1987) A method for computing profile likelihood based confidence bounds. Ann Stat 15:346-359
21. Office of National Statistics (2006) Cancer statistics registrations- series MB1. The Stationery Office, London
22. Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadóttír L, Winther JF, Rechnitzer C, Jonmundsson G, Christensen J, Garwicz S (2009) Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101(11):806-813
23. Pintilie M (2011) An introduction to competing risks analysis. Rev Esp Cardiol 64(7):599-605
24. Preston DL, Lubin JH, Pierce DA (1993) EPICURE user's guide. Hirosoft International Corporation, Seattle
25. Ramé A, Thérond S (2006) Anatomie et physiologie. Elsevier Masson, Issy les Moulineaux, p 318
26. Resche-Rigon M, Azoulay E, Chevret S (2006) Evaluating mortality in intensive care units: contribution of competing risks analyses. Crit Care 10(1):R5
27. Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM (2011) British Childhood Cancer Survivor Study Steering Group. Longterm risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311-2319
28. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, YasuiY, ZeltzerLK(2002) Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 38(4):229-239
29. Ruan PK,Gray RJ (2008)Analyses of cumulative incidence functions via non-parametric multiple imputation. Stat Med 27(27):5709-5724
30. Samartzis D, Nishi N, HayashiM, Cologne J, Cullings HM, Kodama K, Miles EF, Funamoto S, Suyama A, Soda M, Kasagi F (2011) Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki. J Bone Joint Surg Am 93(11):1008-1015
31. Shamsaldin A, Grimaud E, Hardiman C, Diallo I, de-Vathaire F, Chavaudra J (1998) Dose distribution throughout the body from radiotherapy for Hodgkin's disease in childhood. Radiother Oncol 49(1):85-90
32. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD (2005) Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 365(9476):2014-2023
33. Thiebaut AC, Benichou J (2004) Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study. Stat Med 23(24):3803-3820
34. Tucker MA, D'Angio GJ, Boice JD, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W (1987) Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317(10):588-593
35. Wei LJ, Lin DY, Weissfeld L (1989) Regression analysis of multivariate incomplete failure time data by using the marginal distributions. JASA 84:1065-1073
36. Wong FL, Boice JD Jr, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni JF Jr, Li FP (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278(15):1262-1267